These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 32251416
21. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis. van Rooij LC, Wattjes MP, de Jong BA, van Oosten BW. Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475 [Abstract] [Full Text] [Related]
23. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis. Hyun JW, Huh SY, Shin HJ, Woodhall M, Kim SH, Irani SR, Lee SH, Waters P, Kim HJ. Mult Scler; 2019 Apr; 25(4):585-590. PubMed ID: 29512413 [Abstract] [Full Text] [Related]
24. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis. Kim SH, Kwak K, Jeong IH, Hyun JW, Jo HJ, Joung A, Yu ES, Kim JH, Lee SH, Yun S, Joo J, Lee DK, Lee JM, Kim HJ. Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380 [Abstract] [Full Text] [Related]
25. Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Kim H, Lim YM, Kim G, Lee EJ, Lee JH, Kim HW, Kim KK. J Neurol Sci; 2020 Aug 15; 415():116904. PubMed ID: 32446012 [Abstract] [Full Text] [Related]
28. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran. Barzegar M, Badihian S, Mirmosayyeb O, Ashtari F, Jamadi M, Emami S, Jahani L, Safavi A, Shaygannejad V. Mult Scler Relat Disord; 2018 May 15; 22():161-165. PubMed ID: 29775851 [Abstract] [Full Text] [Related]
30. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders. Wang X, Yi H, Liu J, Li M, Mao ZF, Xu L, Peng FH. J Neurol Sci; 2016 Jul 15; 366():3-7. PubMed ID: 27288767 [Abstract] [Full Text] [Related]
34. The utility of diffusion-weighted imaging in patients with spinal cord infarction: difference from the findings of neuromyelitis optica spectrum disorder. Kobayashi M. BMC Neurol; 2022 Oct 11; 22(1):382. PubMed ID: 36221057 [Abstract] [Full Text] [Related]
37. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Huh SY, Min JH, Kim W, Kim SH, Kim HJ, Kim BJ, Kim BJ, Lee KH. Mult Scler; 2014 May 11; 20(6):695-704. PubMed ID: 24072726 [Abstract] [Full Text] [Related]
38. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging. Huang C, Chen W, Liu B, Yu R, Chen X, Tang F, Liu J, Lu W. Front Immunol; 2022 May 11; 13():897959. PubMed ID: 35774780 [Abstract] [Full Text] [Related]
39. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study. Chen X, Roberts N, Zheng Q, Peng Y, Han Y, Luo Q, Zeng C, Wang J, Luo T, Li Y. Mult Scler Relat Disord; 2021 Oct 11; 55():103178. PubMed ID: 34384989 [Abstract] [Full Text] [Related]